EEF1A2 and ovarian carcinoma: In addition to those mentioned in Sect. "Aberrant glycosylation in ovarian cancer", such as high-mannose, sialyl-Lewis X (SLeX), Tn and STn antigens; disialogangliosides GD2 and GD3; the glycolipid Globo-H; and glycosaminoglycans involved in the ECM (HS, DS, CS, and HA), substantial research has indicated the significant involvement of GBPs (Fig. 2).